Treatment of Paclitaxel-Induced Diarrhea

Initial Management Approach

The American Society of Clinical Oncology recommends implementing dietary modifications by eliminating lactose-containing products, alcohol, spicy foods, coffee, and high-osmolar supplements, and encouraging consumption of 8-10 large glasses of clear liquids daily, in patients with paclitaxel-induced diarrhea 1, 2
Patients with paclitaxel-induced diarrhea should reduce intake of insoluble fiber and avoid milk and dairy products (except yogurt and firm cheeses), and monitor and record the number of stools and report any symptoms of life-threatening sequelae, such as fever or dizziness upon standing 2

The American Society of Clinical Oncology recommends starting loperamide at an initial dose of 4 mg followed by 2 mg every 4 hours or after every unformed stool (maximum 16 mg/day), in patients with mild to moderate paclitaxel-induced diarrhea 1, 2
Loperamide should be continued until 12 hours after diarrhea resolves, and solid foods should be gradually reintroduced to the diet as symptoms improve, in patients with paclitaxel-induced diarrhea 1

The American Society of Clinical Oncology recommends increasing loperamide dose to 2 mg every 2 hours, and considering adding oral antibiotics as prophylaxis for infection if risk factors are present, in patients with persistent paclitaxel-induced diarrhea 1, 3

The American Society of Clinical Oncology recommends discontinuing loperamide and switching to second-line agents, such as subcutaneous octreotide at 100-150 μg three times daily, with dose escalation as needed, in patients with refractory paclitaxel-induced diarrhea 1

Patients with suspected bile salt malabsorption should be considered for bile acid sequestrants (cholestyramine, colestipol, colesevelam) as adjuvant therapy, in addition to antidiarrheal medications, to manage paclitaxel-induced diarrhea 2
Fluid and electrolyte replacement is essential alongside antidiarrheal medications, as dehydration is a common complication of chemotherapy-induced diarrhea, and patients should be monitored for signs of dehydration or electrolyte imbalances, which require prompt intervention 1, 2